Oriza, Boyu Join $150M Series A Round In Bio-Pharma Start-Up CStone

Login to View

Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures have invested RMB975 million (US$150 million) in CStone Pharmaceuticals Co., Ltd, a bio-pharmaceutical company devoted to developing new treatments for various major diseases.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS